BiotechTube
Home/Dr. Reddy's Laboratories/Dr. Murali Ramachandra
DM

Dr. Murali Ramachandra

Chief Executive Officer, Aurigene Oncology

Dr. Reddy's Laboratories

Roles

Chief Executive Officer, Aurigene OncologyatDr. Reddy's Laboratories
Chief Executive Officer, Aurigene Oncologyatdr-reddys-laboratories

Therapeutic Areas

OncologyMetabolic Disorders (Diabetes/Obesity)ImmunologyInfectious Diseases (HIV)Central Nervous SystemGastrointestinalPainConsumer Health

Dr. Reddy's Laboratories Pipeline

DrugIndicationPhase
Generic Semaglutide Injection (Obeda)Type 2 DiabetesApproved
Generic Semaglutide (Oral)Type 2 Diabetes, ObesityDevelopment
Bevacizumab BiosimilarVarious CancersApproved
Rituximab BiosimilarNon-Hodgkin Lymphoma, Rheumatoid ArthritisApproved
LenacapavirHIV-1 InfectionApproved
ToripalimabRecurrent/Metastatic Nasopharyngeal CarcinomaApproved
CAR T-Cell Therapy ProgramRelapsed/Refractory Multiple MyelomaDevelopment
Injectable ContraceptiveWomen's Health / Family PlanningDevelopment

Leadership Team at Dr. Reddy's Laboratories

EI
Erez Israeli
Chief Executive Officer
DS
Deepak Sapra
CEO, API & Services
MR
M.V. Ramana
CEO, Branded Markets
KV
Krishna Venkatesh
Global Head of Quality and Pharmacovigilence
DK
Dr. Kallam Anji Reddy
Founder
View full Dr. Reddy's Laboratories profile